Results 41 to 50 of about 1,637,094 (203)

Pharmacogenetics of the human beta-adrenergic receptors [PDF]

open access: yesThe Pharmacogenomics Journal, 2006
The beta-adrenergic receptors (ADRBs) are cell surface receptors that play central roles in the sympathetic nervous system. Pharmacological targeting of two of these receptors, ADRB1 and ADRB2, represents a widely used therapeutic approach for common and important diseases including asthma, hypertension and heart failure.
openaire   +2 more sources

Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer’s disease

open access: yesJournal of Neuroinflammation
Norepinephrine (NE) modulates cognitive function, arousal, attention, and responses to novelty and stress, and it also regulates neuroinflammation. We previously demonstrated behavioral and immunomodulatory effects of beta-adrenergic pharmacology in ...
Andrew K. Evans   +12 more
doaj   +1 more source

Beta Adrenergic Receptors Stimulation Attenuates Phosphorylation of NF-κB and IκBα in Hyperglycemic Endothelial Cells

open access: yesCellular Physiology and Biochemistry, 2018
Background/Aims: NF-κB induces transcription of a number of genes, associated with inflammation and apoptosis. In this study, we have investigated the effect of β-adrenergic receptor stimulation on NF-κB and IκBα in HUVECs.
Sher Zaman  Safi   +6 more
doaj   +1 more source

Compromised trigemino-coerulean coupling in migraine sensitization can be prevented by blocking beta-receptors in the locus coeruleus

open access: yesThe Journal of Headache and Pain, 2023
Background Migraine is a disabling neurological disorder, characterized by recurrent headaches. During migraine attacks, individuals often experience sensory symptoms such as cutaneous allodynia which indicates the presence of central sensitization. This
Jérémy Signoret-Genest   +8 more
doaj   +1 more source

The interaction of verapamil and norverapamil with beta-adrenergic receptors.

open access: yes, 1985
To determine the effect of calcium-channel blockers on beta-adrenergic receptors, we studied the interactions of verapamil, diltiazem, and nifedipine with both human lymphocyte beta 2-adrenergic receptors and rat myocardial beta 1-adrenergic receptors by
G D Park, C Y Lai, R D Feldman
core   +1 more source

Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling

open access: yesBreast Cancer Research, 2022
Background Opioid and beta-adrenergic receptors are recently shown to cross talk via formation of receptor heterodimers to control the growth and proliferation of breast cancer cells.
Bénédicte Rousseau   +3 more
doaj   +1 more source

Beta-blockers reduce intestinal permeability and early mortality following traumatic brain injury in Drosophila

open access: yesmicroPublication Biology, 2021
Traumatic brain injury (TBI) frequently leads to non-neurological consequences such as intestinal permeability. The beta-blocker drug labetalol, which inhibits binding of catecholamine neurotransmitters to adrenergic receptors, reduces intestinal ...
Amanda R Scharenbrock   +4 more
doaj   +1 more source

Molecular and functional identification of beta-adrenergic receptors in distal convoluted tubule cells

open access: yes, 1997
Renal nerve stimulation or circulating catecholamines activate the beta-adrenergic receptors that mediate direct effects on tubular transport. Three subtypes of beta-adrenergic receptors have been characterized: beta 1, beta 2, and beta 3.
F. A. Gesek, K. E. White
core   +1 more source

β adrenergic receptor

open access: yes, 2021
What are adrenergic receptors?
Zahra Amini, Fateme Mousavizade, Negin Azizi
core   +1 more source

Regulation of subtypes of beta-adrenergic receptors in rat brain following treatment with 6-hydroxydopamine

open access: yes, 1989
The technique of quantitative autoradiography has been used to localize changes in the densities of subtypes of beta-adrenergic receptors in rat brain following treatment with 6-hydroxydopamine.
BB Wolfe, PB Molinoff, EW Johnson
core   +1 more source

Home - About - Disclaimer - Privacy